openPR Logo
Press release

Heparin Sodium Market is Set to grow at healthy CAGR from 2023 to 2032 | Latest Trends, Revenue Growth & Key Companies

10-03-2023 11:22 AM CET | Health & Medicine

Press release from: allied market research

/ PR Agency: allied market research
Heparin Sodium Market is Set to grow at healthy CAGR from 2023

According to a new report published by Allied Market Research, Heparin Sodium Market, Heparin sodium is an anticoagulant that is used to prevent blood clots. It is also known as a blood thinner. Heparin sodium is used to treat blood clot formation in the lungs, arteries, and veins. Heparin sodium is also used prior to a surgery to reduce the risk of blood clots.

Request Sample Copy of Report: https://www.alliedmarketresearch.com/request-toc-and-sample/2826

Heparin Sodium Market the market is categorised into unfractionated heparin, low molecular weight heparins, and heparinoids. In terms of application, the market is divided into venous thromboembolism, complications of pregnancy, cardioversion of atrial fibrillation/flutter, and others. Regionally, the market has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Takeaways:

Medical Anticoagulant: Heparin sodium is a widely used medical anticoagulant primarily employed to prevent and treat blood clots, especially in conditions such as deep vein thrombosis, pulmonary embolism, and during surgeries.

Global Demand: The global demand for heparin sodium is significant, driven by the increasing prevalence of cardiovascular diseases, surgeries, and other medical conditions requiring anticoagulation therapy.

Variety of Applications: Heparin sodium is utilized in various medical settings, including hospitals, clinics, and home healthcare, for a range of therapeutic and prophylactic purposes.

Regulatory Oversight: The production and distribution of heparin sodium are subject to stringent regulatory standards and quality control measures due to its critical role in patient safety.

Quality and Safety Concerns: The heparin sodium market has faced safety concerns related to adulteration and contamination in the past, leading to increased scrutiny and quality assurance measures.

Biological Sourcing: Heparin sodium is primarily derived from animal sources, such as pig intestines and bovine lung, which presents challenges related to sustainability and animal welfare concerns.

Research and Development: Ongoing research aims to develop alternative sources and manufacturing processes for heparin sodium to address the limitations associated with animal-derived heparin.

Global Supply Chain: The global supply chain of heparin sodium involves multiple stakeholders, including manufacturers, suppliers, and distributors, and is subject to geopolitical and logistical challenges.

Market Competition: The heparin sodium market is competitive, with several pharmaceutical companies producing and marketing different formulations and dosages of heparin products.

Market Growth: The market is expected to continue growing due to the aging population, increasing surgical procedures, and rising awareness of cardiovascular diseases.

Key Benefits :

The study provides an in-depth analysis of the global heparin sodium market along with the current trends and future estimations to elucidate imminent investment pockets.

Comprehensive analysis of the factors that drive and restrict the market growth has been provided in the report.

Comprehensive quantitative analysis of the industry has been provided to assist stakeholders to capitalize on prevailing market opportunities.

Extensive analysis of key segments of the industry helps understand the trends in the types of heparin sodium globally.

Key market players and their strategies have been provided to understand the competitive outlook of the industry.

For Purchase Enquiry: https://www.alliedmarketresearch.com/purchase-enquiry/3477

Competitive Landscape:

Pharma Action GmbH

Nanjing Xinbai Pharmaceutical Co., Ltd.

Opocrin S.p.A, Sichuan Deebio Pharmaceutical Co.LTD.

Hebei Changshan Biochemical Pharmaceutical Co., Ltd.

Yantai Dongcheng Biochemicals Co. Ltd.

Market Segments:

By Type:

Unfractionated Heparin

Low Molecular Weight Heparins

Heparinoids

By Application:

Venous Thromboembolism

Complications of Pregnancy

Cardioversion of Atrial Fibrillation/Flutter

Others

Market By Geography:

North America

Europe

Asia-Pacific

LAMEA

Obtain Report Details:

https://www.alliedmarketresearch.com/blood-screening-market

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com

Web: www.alliedmarketresearch.com

Allied Market Research Blog: https://blog.alliedmarketresearch.com

Follow Us on | Facebook | LinkedIn | YouTube

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Heparin Sodium Market is Set to grow at healthy CAGR from 2023 to 2032 | Latest Trends, Revenue Growth & Key Companies here

News-ID: 3232769 • Views:

More Releases from allied market research

Switching Mode Power Supply Market Share To Reach $16.4 Billion By 2032
Switching Mode Power Supply Market Share To Reach $16.4 Billion By 2032
The global switching mode power supply market is experiencing growth due to several factors such as increasing demand in healthcare and clinical diagnostics paired with technological advancements and product innovations. Allied Market Research published a report, titled, "Switching Mode Power Supply Market According to the report, the switching mode power supply market was valued at $12.7 billion in 2024, and is estimated to reach $16.4 billion by 2032, growing at
AC-DC Power Supply Adapter Market Size to Reach $24.5 Billion by 2031
AC-DC Power Supply Adapter Market Size to Reach $24.5 Billion by 2031
The AC-DC power supply adapter market is expected to continue growing in the coming years, owing to the surge in demand for efficient and low-voltage high-current processors, the advancements in consumer electronics, medical, and automotive sectors, and technologically advanced AC-DC power supply as an alternative to a conventional electric load, and others during the forecast period. According to a new report published by Allied Market Research, titled, "AC-DC Power Supply Adapter
Multilayer Ceramic Capacitor Market Size to Reach $23.7 Billion by 2032
Multilayer Ceramic Capacitor Market Size to Reach $23.7 Billion by 2032
The growth of the multilayer ceramic capacitor (MLCC) market is significantly influenced by rising demand in consumer electronics, automotive, and telecommunications sectors. Technological advancements enhancing performance and miniaturization are propelling innovation. However, fluctuations in raw material prices and supply chain disruptions pose challenges. Opportunities lie in the increasing adoption of electric vehicles and renewable energy technologies, which require advanced capacitors for efficiency. Additionally, expanding applications in IoT and smart devices
Space Launch Services Market Share to Reach $46.1 Billion by 2033
Space Launch Services Market Share to Reach $46.1 Billion by 2033
By payload, the satellite segment dominated the global market in 2023, in terms of revenue; however, the human spaceflight segment is anticipated to witness highest CAGR growth rate during the forecast period. By launch platform, the land segment accounted for a major share in 2023. By service type, the pre-launch segment accounted for the largest market share in 2023. At present, North America is the highest revenue contributor, followed by

All 5 Releases


More Releases for Heparin

Heparin (Heparin Sodium and Heparin Calcium) Market Size, Overview And Forecast …
"The Global Heparin (Heparin Sodium and Heparin Calcium) Market Size is projected to reach at a CAGR of 3.4% during 2024-2032." Global Heparin (Heparin Sodium and Heparin Calcium) market Size, Status, and Forecast for the 2024-2032. In-depth research has been compiled to provide the most up-to-date information on key aspects of the worldwide market. This research report covers major aspects of the Heparin (Heparin Sodium and Heparin Calcium) Market including
Heparin (Heparin Sodium and Heparin Calcium) Market explores demand trends, grow …
"𝐄𝐦𝐩𝐨𝐰𝐞𝐫𝐢𝐧𝐠 𝐁𝐮𝐬𝐢𝐧𝐞𝐬𝐬𝐞𝐬 𝐰𝐢𝐭𝐡 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐯𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐬 𝐟𝐨𝐫 𝐒𝐦𝐚𝐫𝐭𝐞𝐫 𝐃𝐞𝐜𝐢𝐬𝐢𝐨𝐧-𝐌𝐚𝐤𝐢𝐧𝐠" The global Heparin (Heparin Sodium and Heparin Calcium) market is anticipated to grow from USD 1,202 Million in 2023 to USD 1,509 Million by 2033, at a CAGR of 3.3 % during the forecast period. Heparin (Heparin Sodium and Heparin Calcium) 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐢𝐳𝐞, 𝐒𝐜𝐨𝐩𝐞, 𝐚𝐧𝐝 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝟐𝟎𝟐𝟒-𝟐𝟎𝟑𝟑 𝐫𝐞𝐩𝐨𝐫𝐭 𝐡𝐚𝐬 𝐛𝐞𝐞𝐧 𝐢𝐧𝐜𝐥𝐮𝐝𝐞𝐝 𝐢𝐧 𝐄𝐱𝐚𝐜𝐭𝐢𝐭𝐮𝐝𝐞 𝐂𝐨𝐧𝐬𝐮𝐥𝐭𝐚𝐧𝐜𝐲'𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐜𝐨𝐥𝐥𝐞𝐜𝐭𝐢𝐨𝐧. Heparin (Heparin Sodium and Heparin Calcium) Market
Heparin Market Report 2023 | Increasing the Advantages of Low Molecular Weight H …
According to Precision Business Insights (PBI), the latest report the global heparin market size was valued at USD 7,923.7 million in 2022 and is projected to grow at a 2.8% CAGR during the forecast period 2023 to 2029. The efficacy of these drugs as an anticoagulant is one of the key factors expected to drive global market growth. Furthermore, undeniable factors such as technological advancement and introducing of new products
Heparin Market
The heparin market refers to the global market for heparin, a blood-thinning medication that is commonly used in the prevention and treatment of blood clots. Heparin is typically derived from the mucous membranes of animals such as pigs and cows, and it is commonly used in a variety of medical settings, including hospitals, clinics, and home care settings. The heparin market has experienced steady growth over the past few years, driven
Global Heparin(Heparin Sodium and Heparin Calcium) Market drivers, restraints, g …
Latest industry research report on: Global Heparin(Heparin Sodium and Heparin Calcium) Market : Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts This report studies the global Heparin(Heparin Sodium and Heparin Calcium) market status and forecast, categorizes the global Heparin(Heparin Sodium and Heparin Calcium) market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China,
Heparin Market: Rapid Growth of Heparin Market Anticipated in Several European N …
Europe is among the major regions contributing to the global heparin market owing to its developed economy and high prevalence of coagulation disorders. According to the Ageing Report published by the European Commission in 2015, the percentage of population aged above 65 years is expected to increase from 21.0% in 2013 to 32.0% in 2060. Aging is directly proportional to the rising incidence of venous thromboembolism (VTE) diseases such as